SW
AKYA

SVB Wealth’s Akoya BioSciences AKYA Stock Holding History

SVB Wealth’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-81
Closed -$113 – 479
2025
Q1 		$113 Sell
81
-515,317
-100% -$1.13M ﹤0.01% 1498
2024
Q4 		$1.18M Buy
+515,398
New +$1.37M 0.02% 288
2024
Q3 		– Sell
-515,317
Closed -$1.21M – 40
2024
Q2 		$1.21M Hold
515,317
– – 0.03% 284
2024
Q1 		$2.42M Hold
515,317
– – 0.05% 227
2023
Q4 		$2.51M Hold
515,317
– – 0.06% 219
2023
Q3 		$2.4M Buy
515,317
+15,400
+3% +$88.5K 0.05% 207
2023
Q2 		$3.69M Hold
499,917
– – 0.07% 179
2023
Q1 		$4.09M Sell
499,917
-17,040
-3% -$178K 0.06% 190
2022
Q4 		$4.95M Buy
+516,957
New +$6.36M 0.07% 177

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SVB Wealth's AKYA Position: Q2 2025 in Review

SVB Wealth sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 81 shares — an estimated $113 sold.

SVB Wealth first reported a position in AKYA in Q4 2022 and held it in 9 quarters. The position peaked at $4.95M in Q4 2022. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • SVB Wealth reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 81 Akoya BioSciences shares in Q2 2025, an estimated $113.
  • SVB Wealth first reported a position in Akoya BioSciences in Q4 2022 and held it in 9 quarters.
  • SVB Wealth's Akoya BioSciences position peaked at $4.95M in Q4 2022.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.